EUVIMEDEUVIMED entdecken
FallberichtOpen Access

[ 68 Ga]-DOTATATE PET Standardized Uptake Value Reduction after Bevacizumab in High-grade Meningioma: A Potential Treatment Response Biomarker

Kellen Vo Vu iD, Hannah G Otis, Andrew Brandmaier, Joseph R Osborne iD, Philip E Stieg iD, Rohan R Ramakrishna iD, Arsalan Haghdel iD, Sean H Kim iD, Benjamin Liechty, Kate Rosen, Kathryn Beal, Susan C Pannullo und 6 weitere

American Journal of Neuroradiology · 2026-09 · 47 (9) · 2342-2347

DOI: 10.3174/ajnr.a9260 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Neuroradiology, online erschienen am 23.02.2026. Verfasst von Kellen Vo Vu und 17 weiteren Autor:innen. Beteiligte Einrichtung: From the MD Program (K.V.V., H.G.O.), Weill Cornell Medicine, New York, New York. Hauptthemen laut MEDLINE: Bevacizumab, Meningeal Neoplasms, Meningioma, Organometallic Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Novartis Pharmaceuticals Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BevacizumabMeningeal NeoplasmsMeningiomaOrganometallic CompoundsPositron-Emission TomographyHumansMaleMiddle AgedAngiogenesis InhibitorsAntineoplastic Agents, ImmunologicalBiomarkers, TumorRadiopharmaceuticalsTreatment OutcomeAged, 80 and over

Substanzen

Angiogenesis InhibitorsAntineoplastic Agents, ImmunologicalBevacizumabBiomarkers, Tumorgallium Ga 68 dotatateOrganometallic CompoundsRadiopharmaceuticals

Autor:innen und Institutionen

  • From the MD Program (K.V.V., H.G.O.), Weill Cornell Medicine, New York, New York.
  • Department of Radiation Oncology (A.B., K.B., J.P.S.K.), Weill Cornell Medicine, New York, New York.
  • Department of Diagnostic Radiology (J.R.O., A.H., S.H.K., J.I.), Weill Cornell Medicine, New York, New York.
  • Department of Neurological Surgery (P.E.S., R.R.R., K.R.), Weill Cornell Medicine, New York, New York.
  • Department of Pathology (B.L.), Weill Cornell Medicine, New York, New York.
  • Hackensack Meridian Health (S.C.P.), West Orange, New Jersey.

ORCID-Profile: Kellen Vo Vu, Joseph R Osborne, Philip E Stieg, Rohan R Ramakrishna, Arsalan Haghdel, Sean H Kim, Jonathan P S Knisely, Rajiv S Magge, Peter C Pan, Jana Ivanidze

Förderung

  • Novartis Pharmaceuticals Corporation

Zitieren

APA

Vu, K. V., Otis, H. G., Brandmaier, A., Osborne, J. R., Stieg, P. E., Ramakrishna, R. R., Haghdel, A., Kim, S. H., Liechty, B., Rosen, K., Beal, K., Pannullo, S. C., Knisely, J. P. S., Magge, R. S., Welch, M., Iwamoto, F., Pan, P. C., & Ivanidze, J. (2026). [ 68 Ga]-DOTATATE PET Standardized Uptake Value Reduction after Bevacizumab in High-grade Meningioma: A Potential Treatment Response Biomarker. American Journal of Neuroradiology, 47(9), 2342-2347. https://doi.org/10.3174/ajnr.a9260

Vancouver

Vu KV, Otis HG, Brandmaier A, Osborne JR, Stieg PE, Ramakrishna RR, et al. [ 68 Ga]-DOTATATE PET Standardized Uptake Value Reduction after Bevacizumab in High-grade Meningioma: A Potential Treatment Response Biomarker. American Journal of Neuroradiology. 2026;47(9):2342-2347. doi:10.3174/ajnr.a9260

BibTeX
@article{Vu2026,
  author = {Vu, Kellen Vo and Otis, Hannah G and Brandmaier, Andrew and Osborne, Joseph R and Stieg, Philip E and Ramakrishna, Rohan R and Haghdel, Arsalan and Kim, Sean H and Liechty, Benjamin and Rosen, Kate and Beal, Kathryn and Pannullo, Susan C and Knisely, Jonathan P S and Magge, Rajiv S and Welch, Mary and Iwamoto, Fabio and Pan, Peter C and Ivanidze, Jana},
  title = {[ 68 Ga]-DOTATATE PET Standardized Uptake Value Reduction after Bevacizumab in High-grade Meningioma: A Potential Treatment Response Biomarker},
  journal = {American Journal of Neuroradiology},
  year = {2026},
  volume = {47},
  number = {9},
  pages = {2342--2347},
  doi = {10.3174/ajnr.a9260}
}
Kostenlos starten →